Personal information

Other IDs

Scopus Author ID: 55620670700

Activities

Collapse all

Works (28)

Association among metabolic syndrome, inflammation, and survival in prostate cancer

Urologic Oncology: Seminars and Original Investigations
2018 | Journal article
DOI: 10.1016/j.urolonc.2018.01.007
EID:

2-s2.0-85041583351
Contributors: Conteduca, V.; Caffo, O.; Galli, L.; Maugeri, A.; Scarpi, E.; Maines, F.; Chiuri, V.E.; Lolli, C.; Kinspergher, S.; Schepisi, G. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Detection of a CDH1 rare transcript variant in fresh-frozen gastric cancer tissues by chip-based digital PCR

Journal of Visualized Experiments
2018 | Journal article
DOI: 10.3791/57066
EID:

2-s2.0-85042025905
Contributors: Molinari, C.; Khouzam, R.A.; Salvi, S.; Rossi, T.; Ranzani, G.N.; Calistri, D.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

GSTP1 methylation in cancer: A liquid biopsy biomarker?

Clinical Chemistry and Laboratory Medicine
2018 | Journal article
DOI: 10.1515/cclm-2017-0703
EID:

2-s2.0-85040933482
Contributors: Gurioli, G.; Martignano, F.; Salvi, S.; Costantini, M.; Gunelli, R.; Casadio, V.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study

Annals of Oncology
2017 | Journal article
DOI: 10.1093/annonc/mdx155
EID:

2-s2.0-85019315640
Contributors: Conteduca, V.; Wetterskog, D.; Sharabiani, M.T.A.; Grande, E.; Fernandez-Perez, M.P.; Jayaram, A.; Salvi, S.; Castellano, D.; Romanel, A.; Lolli, C. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer

Oncotarget
2017 | Journal article
DOI: 10.18632/oncotarget.15120
EID:

2-s2.0-85014596097
Contributors: Maltoni, R.; Casadio, V.; Ravaioli, S.; Foca, F.; Tumedei, M.M.; Salvi, S.; Martignano, F.; Calistri, D.; Rocca, A.; Schirone, A. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Cell-free DNA integrity analysis in urine samples

Journal of Visualized Experiments
2017 | Journal article
DOI: 10.3791/55049
EID:

2-s2.0-85011620946
Contributors: Casadio, V.; Salvi, S.; Martignano, F.; Gunelli, R.; Ravaioli, S.; Calistri, D.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer

Scientific Reports
2017 | Journal article
DOI: 10.1038/s41598-017-15928-y
EID:

2-s2.0-85034090227
Contributors: Conteduca, V.; Scarpi, E.; Caroli, P.; Salvi, S.; Lolli, C.; Burgio, S.L.; Menna, C.; Schepisi, G.; Testoni, S.; Gurioli, G. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer

Oncotarget
2017 | Journal article
DOI: 10.18632/oncotarget.13401
EID:

2-s2.0-85015780790
Contributors: Khouzam, R.A.; Molinari, C.; Salvi, S.; Marabelli, M.; Molinaro, V.; Orioli, D.; Saragoni, L.; Morgagni, P.; Calistri, D.; Ranzani, G.N.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone

Prostate
2017 | Journal article
DOI: 10.1002/pros.23357
EID:

2-s2.0-85018635498
Contributors: Conteduca, V.; Caffo, O.; Lolli, C.; Aieta, M.; Scarpi, E.; Bianchi, E.; Maines, F.; Schepisi, G.; Salvi, S.; Massari, F. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Serum and plasma copy number detection using real-time PCR

Journal of Visualized Experiments
2017 | Journal article
DOI: 10.3791/56502
EID:

2-s2.0-85037696366
Contributors: Salvi, S.; Conteduca, V.; Martignano, F.; Gurioli, G.; Calistri, D.; Casadio, V.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs

Nature Communications
2017 | Journal article
DOI: 10.1038/s41467-017-01562-9
EID:

2-s2.0-85035772551
Contributors: Vannini, I.; Wise, P.M.; Challagundla, K.B.; Plousiou, M.; Raffini, M.; Bandini, E.; Fanini, F.; Paliaga, G.; Crawford, M.; Ferracin, M. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

AR copy number and AR signaling-directed therapies in castration-resistant prostate cancer.

Current cancer drug targets
2017-11 | Journal article
DOI: 10.2174/1568009617666171122145852
PMID: 29173173
Contributors: Salvi S; Conteduca V; Lolli C; Testoni S; Casadio V; Zaccheroni A; Rossi L; Burgio SL; Menna C; Schepisi G et al.
Source: Self-asserted source
Samanta Salvi via Europe PubMed Central

Vitamin D status among long-term survivors of testicular cancer.

Oncotarget
2017-05 | Journal article
DOI: 10.18632/oncotarget.14167
PMID: 28030821
PMC: PMC5482697
Contributors: Schepisi G; De Padova S; Scarpi E; Lolli C; Gurioli G; Menna C; Burgio SL; Rossi L; Gallà V; Casadio V et al.
Source: Self-asserted source
Samanta Salvi via Europe PubMed Central

Cell-free DNA as a diagnostic marker for cancer: Current insights

OncoTargets and Therapy
2016 | Journal article
DOI: 10.2147/OTT.S100901
EID:

2-s2.0-84993967978
Contributors: Salvi, S.; Gurioli, G.; De Giorgi, U.; Conteduca, V.; Tedaldi, G.; Calistri, D.; Casadio, V.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer

Oncotarget
2016 | Journal article
DOI: 10.18632/oncotarget.9341
EID:

2-s2.0-84978134356
Contributors: Salvi, S.; Casadio, V.; Conteduca, V.; Lolli, C.; Gurioli, G.; Martignano, F.; Schepisi, G.; Testoni, S.; Scarpi, E.; Amadori, D. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone

International Journal of Biological Markers
2016 | Journal article
DOI: 10.5301/jbm.5000197
EID:

2-s2.0-84982969033
Contributors: Salvi, S.; Casadio, V.; Burgio, S.L.; Conteduca, V.; Rossi, L.; Menna, C.; Carretta, E.; Costantini, M.; Zoli, W.; De Giorgi, U.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Emerging mutations and functional changes of androgen receptor associated with treatment resistance in prostate cancer

Translational Cancer Research
2016 | Journal article
DOI: 10.21037/tcr.2016.10.58
EID:

2-s2.0-84996912580
Contributors: Martignano, F.; Lolli, C.; Ravaglia, G.; Gall�, V.; Gurioli, G.; Salvi, S.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications

Disease Markers
2016 | Journal article
DOI: 10.1155/2016/4358292
EID:

2-s2.0-84983776591
Contributors: Martignano, F.; Gurioli, G.; Salvi, S.; Calistri, D.; Costantini, M.; Gunelli, R.; De Giorgi, U.; Foca, F.; Casadio, V.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview

Molecular Diagnosis and Therapy
2016 | Journal article
DOI: 10.1007/s40291-015-0169-9
EID:

2-s2.0-84956694666
Contributors: Salvi, S.; Conteduca, V.; Gurioli, G.; Calistri, D.; Casadio, V.; De Giorgi, U.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Methylation pattern analysis in prostate cancer tissue: Identification of biomarkers using an MS-MLPA approach

Journal of Translational Medicine
2016 | Journal article
DOI: 10.1186/s12967-016-1014-6
EID:

2-s2.0-84984629917
Contributors: Gurioli, G.; Salvi, S.; Martignano, F.; Foca, F.; Gunelli, R.; Costantini, M.; Cicchetti, G.; Giorgi, U.; Sbarba, P.D.; Calistri, D. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer

OncoTargets and Therapy
2016 | Journal article
DOI: 10.2147/OTT.S105760
EID:

2-s2.0-84966769142
Contributors: Molinari, C.; Salvi, S.; Foca, F.; Teodorani, N.; Saragoni, L.; Puccetti, M.; Passardi, A.; Tamberi, S.; Avanzolini, A.; Lucci, E. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

The potential use of urine cell free DNA as a marker for cancer

Expert Review of Molecular Diagnostics
2016 | Journal article
DOI: 10.1080/14737159.2016.1254551
EID:

2-s2.0-84996938017
Contributors: Salvi, S.; Martignano, F.; Molinari, C.; Gurioli, G.; Calistri, D.; De Giorgi, U.; Conteduca, V.; Casadio, V.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy

BioDrugs
2016 | Journal article
DOI: 10.1007/s40259-016-0176-3
EID:

2-s2.0-84968593899
Contributors: Schepisi, G.; Santoni, M.; Massari, F.; Gurioli, G.; Salvi, S.; Conteduca, V.; Montironi, R.; De Giorgi, U.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone

British Journal of Cancer
2015 | Journal article
DOI: 10.1038/bjc.2015.128
EID:

2-s2.0-84929292191
Contributors: Salvi, S.; Casadio, V.; Conteduca, V.; Burgio, S.L.; Menna, C.; Bianchi, E.; Rossi, L.; Carretta, E.; Masini, C.; Amadori, D. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Plasma AR and abiraterone-resistant prostate cancer

Science Translational Medicine
2015 | Journal article
DOI: 10.1126/scitranslmed.aac9511
EID:

2-s2.0-84947245381
Contributors: Romanel, A.; Tandefelt, D.G.; Conteduca, V.; Jayaram, A.; Casiraghi, N.; Wetterskog, D.; Salvi, S.; Amadori, D.; Zafeiriou, Z.; Rescigno, P. et al.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients

Disease Markers
2015 | Journal article
DOI: 10.1155/2015/574120
EID:

2-s2.0-84941039754
Contributors: Salvi, S.; Gurioli, G.; Martignano, F.; Foca, F.; Gunelli, R.; Cicchetti, G.; De Giorgi, U.; Zoli, W.; Calistri, D.; Casadio, V.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer

International Journal of Molecular Sciences
2014 | Journal article
DOI: 10.3390/ijms150712458
EID:

2-s2.0-84904307868
Contributors: Salvi, S.; Calistri, D.; Gurioli, G.; Carretta, E.; Serra, L.; Gunelli, R.; Zoli, W.; Casadio, V.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier

Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: A pilot study

BioMed Research International
2013 | Journal article
DOI: 10.1155/2013/270457
EID:

2-s2.0-84874826585
Contributors: Casadio, V.; Calistri, D.; Salvi, S.; Gunelli, R.; Carretta, E.; Amadori, D.; Silvestrini, R.; Zoli, W.
Source: Self-asserted source
Samanta Salvi via Scopus - Elsevier
How many people are using ORCID?